Rhythm360 for Providers vs Emmitec WL1使用状況と統計
Rhythm360 is a cloud-based universal cardiac data platform for implanted devices, wearables, and at-home connected devices that lets clinicians incorporate notation, e-signing, and billing into their everyday clinical for managing cardiac data.
This app is for providers only.
- Apple App ストア
- 無料
- 医学
ストアランキング
- -
Health, Wellness and Fitness App
Vital signs are gathered from standard, non medical of the shelf BLE 4.0 or newer gadgets for uploading information to user's account.
No data is stored in iPhone.
All data is handled encrypted in the servers.
App is 100% HIPAA Compliance.
Users can edit and/or delete their accounts directly from the App.
New gadgets are being incorporated constantly, the list of actual gadgets included in this app can be found in gadget's list in the app.
Please seek a doctor’s advice in addition to using this app and before making any medical decisions.
Jurisdiction Statement.
This application is intended for use only with medical devices that have been approved by recognized regulatory authorities, such as the FDA (United States), European Union regulatory bodies, ANVISA (Brazil), and other relevant certification organizations, as applicable in different regions (e.g., Americas, Europe). For detailed information about compliance and certification, please refer to the certification information provided via the link above.
This App can be used in the USA, North, Central and South America and Europe, according to all the certifications granted to the BLE Gadgets from the FDA, EU (European Regulations) and Anvisa.
For more information, there are links in the app where all certifications can be found.
- Apple App ストア
- 無料
- ヘルス & フィットネス
ストアランキング
- -
Rhythm360 for Providers対Emmitec WL1ランキング比較
と過去28日間の Rhythm360 for Providers ランキング傾向を比較 Emmitec WL1
ランキング
ご利用可能なデータがありません
Rhythm360 for Providers 対 Emmitec WL1 国の比較によるランキング
と過去28日間の Rhythm360 for Providers ランキング傾向を比較 Emmitec WL1
表示できるデータはありません
無料トライアルで任意のサイトと比較する
Rhythm360 for Providers VS.
Emmitec WL1
12月 25, 2024